SRC and breast carcinoma: Since statins oppose YAP nuclear localization and transcriptional responses induced by YAP in MDA-MB-231 and other breast cancer cells14, we wanted to assess whether cerivastatin can reverse the action of RA on the Src-YAP-IL6 axis in MDA-MB-231 breast cancer cells and decrease cell invasion and viability.